Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Satsuma Pharmaceuticals Inc (NQ: STSA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 1.060 (5)
Ask (Size) 1.100 (5)
Prev. Close 1.100
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 33,152,498
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed higher by over 160 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSA
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

More News

Read More
SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSA
From Kahn Swick & Foti, LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
Via Benzinga
Crude Oil Down 2%; State Street Shares Tumble After Downbeat Results
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Gold Drops Below $2,000; Charles Schwab Earnings Top Views
Via Benzinga
STSA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Satsuma Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Why Is SAI.TECH Global (SAI) Stock Down 32% Today?
Via InvestorPlace
Why Is Marpai (MRAI) Stock Down 40% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?
Via InvestorPlace
Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Is Satsuma Pharmaceuticals (STSA) Stock Up 144% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Despite Trial Failure, Satsuma Pharma Says Its Migraine Candidate Has Potential For Approval
Via Benzinga
Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for Satsuma Pharmaceuticals: Here's What You Need To Know
Via Benzinga
Expert Ratings for Satsuma Pharmaceuticals
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.